We are live on ! Find out more
WVE icon

Wave Life Sciences

100 hedge funds and large institutions have $795M invested in Wave Life Sciences in 2019 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 48 increasing their positions, 20 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

140% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 20

60% more call options, than puts

Call options by funds: $5.24M | Put options by funds: $3.27M

2.92% more ownership

Funds ownership: 85.99%88.91% (+2.9%)

9% less funds holding

Funds holding: 110100 (-10)

26% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 27

30% less capital invested

Capital invested by funds: $1.14B → $795M (-$347M)

67% less funds holding in top 10

Funds holding in top 10: 62 (-4)

Holders
100
Holders Change
-10
Holders Change %
-9.09%
% of All Funds
2.17%
Holding in Top 10
2
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-66.67%
% of All Funds
0.04%
New
20
Increased
48
Reduced
20
Closed
27
Calls
$5.24M
Puts
$3.27M
Net Calls
+$1.98M
Net Calls Change
+$5.55M
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$2.36M +$218K +7,769 +9%
D.E. Shaw & Co
27
D.E. Shaw & Co
New York
$2.24M -$4.39M -156,665 -65%
B
28
Bailard
California
$2.17M +$1.15M +41,000 +98%
CM
29
Caption Management
Oklahoma
$2.1M +$2.26M +80,600 New
N
30
Nuveen
North Carolina
$2.03M +$2.18M +77,725 New
WC
31
Wexford Capital
Florida
$2.02M +$561K +20,000 +35%
PIM
32
Platinum Investment Management
Australia
$1.85M +$653K +23,294 +49%
FI
33
Fosun International
China
$1.84M +$308K +11,000 +19%
WM
34
WS Management
Florida
$1.61M -$207K -7,392 -11%
MC
35
Matisse Capital
Oregon
$1.59M +$441K +15,715 +35%
CCP
36
Clough Capital Partners
Massachusetts
$1.57M +$244K +8,700 +17%
Citadel Advisors
37
Citadel Advisors
Florida
$1.49M -$644K -22,954 -29%
TCM
38
Tekla Capital Management
Massachusetts
$1.46M +$718K +25,619 +84%
PP
39
PDT Partners
New York
$1.34M +$794K +28,310 +122%
USAA
40
United Services Automobile Association
Texas
$1.27M +$1.36M +48,388 New
Point72 Asset Management
41
Point72 Asset Management
Connecticut
$1.14M -$15.1M -538,811 -93%
JP Morgan Chase
42
JP Morgan Chase
New York
$1.11M -$2.43M -86,627 -67%
Allianz Asset Management
43
Allianz Asset Management
Germany
$1.08M -$1.78M -63,354 -60%
California State Teachers Retirement System (CalSTRS)
44
California State Teachers Retirement System (CalSTRS)
California
$905K +$104K +3,724 +12%
Swiss National Bank
45
Swiss National Bank
Switzerland
$892K +$22.4K +800 +2%
Bank of America
46
Bank of America
North Carolina
$843K +$131K +4,682 +17%
State of Wisconsin Investment Board
47
State of Wisconsin Investment Board
Wisconsin
$764K +$168K +6,000 +26%
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$745K +$82.3K +2,934 +11%
New York State Common Retirement Fund
49
New York State Common Retirement Fund
New York
$652K +$216K +7,700 +45%
DekaBank Deutsche Girozentrale
50
DekaBank Deutsche Girozentrale
Germany
$604K +$645K +23,000 New

WVE Hedge Fund Activity: Q2 2019 in Review

100 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q2 2019, worth a combined $795M — down 30% from $1.14B a quarter earlier.

Sellers outnumbered buyers: 27 funds closed out of WVE and 20 opened new positions — a net loss of 7 holders — while 20 trimmed existing stakes and 48 added.

The largest buyer was Wellington Management Group, adding an estimated $69.7M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $35.1M sold.

  • 100 institutional investors held Wave Life Sciences (WVE) as of Q2 2019, down from 110 in Q1 2019.
  • Funds reported $795M of Wave Life Sciences stock for Q2 2019, down 30% quarter-over-quarter.
  • 20 funds opened new Wave Life Sciences positions in Q2 2019 and 27 closed out, a net change of -7 holders.
  • The largest Wave Life Sciences buyer in Q2 2019 was Wellington Management Group, an estimated $69.7M added.
  • The largest Wave Life Sciences seller in Q2 2019 was PFM Health Sciences, an estimated $35.1M sold.

Based on aggregated 13F filings for Q2 2019.